Lader M H
Zh Nevropatol Psikhiatr Im S S Korsakova. 1975;75(9):1401-5.
The author examined a group of drug-free patients who during the subsequent period of I month received chlorpromazine. These patients were studied for the chlorpromazine content in the blood, pupilzise, handwriting test, EEG and mental state. The level of chlorpromasine was maximal in the first 2 weeks and then declined. Changes in the peripheral autonomic measures correlated with those in the plasma levels and with an increased liver hydrozylation. Changes in the central measures were inconsistent. A 3-week treatment with phenobarbitone and antiparkinsonic drugs accelerated the metabolism of chlorpromazine. An increased metabolism of chlorpromazine in the intestine and liver may be the cause of the patients' resistanec to chlorpromazine therapy.
作者检查了一组未服用药物的患者,这些患者在随后的1个月内接受了氯丙嗪治疗。对这些患者进行了血液中氯丙嗪含量、瞳孔大小、笔迹测试、脑电图和精神状态的研究。氯丙嗪水平在最初2周达到最高,然后下降。外周自主神经指标的变化与血浆水平的变化以及肝脏羟化作用增强相关。中枢指标的变化并不一致。用苯巴比妥和抗帕金森病药物进行3周治疗加速了氯丙嗪的代谢。氯丙嗪在肠道和肝脏中的代谢增加可能是患者对氯丙嗪治疗产生耐药性的原因。